Artwork

Indhold leveret af Stephen Cass and IEEE Spectrum. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Stephen Cass and IEEE Spectrum eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !

The Brain Implant That Sidesteps The Competition

26:54
 
Del
 

Manage episode 397336649 series 2805647
Indhold leveret af Stephen Cass and IEEE Spectrum. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Stephen Cass and IEEE Spectrum eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

We've all seen impressive demos of prototype brain implants being used by paralyzed patients to interface with computers, but none of those implants have entered general clinical use. Biomedical device company Synchron is close to actually coming to market with its stentrode technology, promising less spectacular results than some of its competitors, but making up for that with ease of use and implant longevity. Synchron's co-founder Tom Oxley talks with IEEE Spectrum senior editor Eliza Strickland about the new tech, and you can read more in our January issue article by Emily Waltz.

  continue reading

66 episoder

Artwork
iconDel
 
Manage episode 397336649 series 2805647
Indhold leveret af Stephen Cass and IEEE Spectrum. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Stephen Cass and IEEE Spectrum eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.

We've all seen impressive demos of prototype brain implants being used by paralyzed patients to interface with computers, but none of those implants have entered general clinical use. Biomedical device company Synchron is close to actually coming to market with its stentrode technology, promising less spectacular results than some of its competitors, but making up for that with ease of use and implant longevity. Synchron's co-founder Tom Oxley talks with IEEE Spectrum senior editor Eliza Strickland about the new tech, and you can read more in our January issue article by Emily Waltz.

  continue reading

66 episoder

Todos os episódios

×
 
Loading …

Velkommen til Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Hurtig referencevejledning